Table 3.
Changes of finger JSD of MCP (from thumb to little finger) based on DAS28 remission for RA patients treated with CZP 400 mg plus MTX (*P < 0.01; **P = n. s)
| Finger joint space distance | Baseline mean (SD) in mm |
Week 52 mean (SD) in mm |
Difference | |
|---|---|---|---|---|
| DAS28 ≤ 2.6 | JSD-MCPthumb | 0.147 ± 0.044 | 0.147 ± 0.051 | 0%** |
| JSD-MCPindex finger | 0.160 ± 0.060 | 0.169 ± 0.055 | + 5.6%* | |
| JSD-MCPmiddle finger | 0.157 ± 0.038 | 0.162 ± 0.038 | + 3.2%* | |
| JSD-MCPring finger | 0.153 ± 0.024 | 0.156 ± 0.022 | + 2.0%* | |
| JSD-MCPlittle | 0.142 ± 0.031 | 0.148 ± 0.033 | + 4.2%* | |
| JSD-MCPtotal | 0.152 ± 0.033 | 0.157 ± 0.034 | + 3.3%* | |
| DAS28 > 2.6 | JSD-MCPthumb | 0.147 ± 0.042 | 0.146 ± 0.043 | − 0.7%** |
| JSD-MCPindex finger | 0.149 ± 0.061 | 0.147 ± 0.063 | − 1.3%** | |
| JSD-MCPmiddle finger | 0.139 ± 0.049 | 0.139 ± 0.054 | 0%** | |
| JSD-MCPring finger | 0.147 ± 0.036 | 0.148 ± 0.038 | + 0.7%** | |
| JSD-MCPlittle | 0.142 ± 0.033 | 0.142 ± 0.039 | 0%** | |
| JSD-MCPtotal | 0.145 ± 0.034 | 0.144 ± 0.036 | − 0.7%** |